Medication info

Imetina 200 mg (Cimetidine)

Prescription medicationExpired
Ingredient · strength
Cimetidine›Strength being verified
Manufacturer / importer
Chodang Pharmaceutical Co., Ltd.
Appearance
Light green film-coated tablet
Packaging
30, 600 tablets/bottle
Approval status
Expired

MFDS item code 201308339 · Approved 2013.07.22

This product's status changed to Expired on 2023.07.22. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of acid-related disorders (such as ulcers and gastroesophageal reflux disease); improvement of gastric mucosal lesions in gastritis
Who uses it
Adults · Children
Adult dosage
Adults: Administer cimetidine 400 mg orally twice daily (in the morning and at bedtime), or 800 mg once daily (at bedtime). Alternatively, administer 300 mg orally 4 times daily (after meals and at bedtime). The dose may be increased to 400 mg 4 times daily (after meals and at bedtime; total 1.6 g). However, for improvement of gastric mucosal lesions (erosion, bleeding, erythema, edema) in the following conditions—acute gastritis and acute exacerbation of chronic gastritis—administer 200 mg twice daily or 400 mg once daily. An antacid may be administered as needed to relieve pain. The dose may be increased depending on the patient; in this case, increase the frequency of administration rather than the dose per administration. Do not exceed 2.4 g per day. Patients with renal impairment: Administer 300 mg of this medicine twice daily, every 12 hours. If necessary, depending on the patient's symptoms, the frequency may be increased to 3 times daily, every 8 hours, or more often; use caution. In patients with severe renal impairment, the medicine may accumulate in the body, so reduce the frequency of administration to the minimum necessary according to the patient's response. Hemodialysis lowers blood cimetidine levels. After hemodialysis is completed, administer the medicine again according to the schedule. Adjust the dose as appropriate according to age and symptoms.
Children's dosage
Children: Administer 20 〜 40 mg per kg of body weight per day orally in divided doses.

Ingredients

Manufacturer
Chodang Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of acid-related disorders (such as ulcers and gastroesophageal reflux disease); improvement of gastric mucosal lesions in gastritis

  • Gastric ulcer
  • duodenal ulcer
  • gastroesophageal reflux disease
  • recurrent ulcer
  • anastomotic ulcer
  • Zollinger-Ellison syndrome
  • gastric mucosal lesions
  • erosion
  • bleeding
  • redness
  • swelling
  • acute gastritis
View approved original text

This medication is used for the treatment of gastrointestinal disorders including gastric and duodenal ulcers, gastroesophageal reflux disease, recurrent ulcers, anastomotic ulcers, and Zollinger-Ellison syndrome. It also helps improve gastric mucosal damage (erosion, bleeding, redness, swelling) that occurs during acute exacerbation of acute and chronic gastritis. This medication aids in the recovery of gastric mucosal damage and alleviates symptoms to improve the digestive health of patients.

Dosage and Administration

Adult dosage

Adults: Administer cimetidine 400 mg orally twice daily (in the morning and at bedtime), or 800 mg once daily (at bedtime). Alternatively, administer 300 mg orally 4 times daily (after meals and at bedtime). The dose may be increased to 400 mg 4 times daily (after meals and at bedtime; total 1.6 g). However, for improvement of gastric mucosal lesions (erosion, bleeding, erythema, edema) in the following conditions—acute gastritis and acute exacerbation of chronic gastritis—administer 200 mg twice daily or 400 mg once daily. An antacid may be administered as needed to relieve pain. The dose may be increased depending on the patient; in this case, increase the frequency of administration rather than the dose per administration. Do not exceed 2.4 g per day. Patients with renal impairment: Administer 300 mg of this medicine twice daily, every 12 hours. If necessary, depending on the patient's symptoms, the frequency may be increased to 3 times daily, every 8 hours, or more often; use caution. In patients with severe renal impairment, the medicine may accumulate in the body, so reduce the frequency of administration to the minimum necessary according to the patient's response. Hemodialysis lowers blood cimetidine levels. After hemodialysis is completed, administer the medicine again according to the schedule. Adjust the dose as appropriate according to age and symptoms.

Children's dosage

Children: Administer 20 〜 40 mg per kg of body weight per day orally in divided doses.

Precautions

This medication may contain glass fragments when using ampoule injections; therefore, care should be taken when cutting the injection container. Extra caution is required, especially when used by children and elderly patients. Patients with a history of allergic reactions to cimetidine or any other components of this medication, or those taking dofetilide should not use it. There is an increased risk of cardiac arrhythmias when used with dofetilide. Patients with impaired kidney or liver function, those with a history of drug allergies, elderly patients, children under 19 years of age, and patients undergoing hemodialysis should use this medication cautiously. Particularly, it is advisable for hemodialysis patients to administer this medication after dialysis. This medication may mask symptoms of gastric cancer, so it should only be used after confirming that it is not gastric cancer, and patients with Helicobacter pylori infection and gastric/duodenal ulcers require bacterial eradication therapy. When taking this medication, various side effects such as decreased blood cell count, liver dysfunction, renal impairment, allergic reactions, endocrine disorders, gastrointestinal symptoms, neurological abnormalities, cardiac issues, skin disorders may occur, so if any unusual symptoms arise, immediate consultation with a physician is recommended. During treatment, the progress of the disease should be closely monitored, and only the minimum required dose should be used. If there is no effect, it is advisable to switch to other treatments. In particular, elderly patients or those with a history of peptic ulcers should be monitored regularly. This medication has many drug interactions, and dosing adjustments or drug holidays may be necessary for other medications being taken concurrently, so patients should inform about any medications they are taking. Women who are pregnant or may become pregnant should carefully weigh the risks and benefits of using this medication, and breastfeeding women are advised to discontinue breastfeeding. The safety for children has not been established, so it should only be used when absolutely necessary, and elderly patients may require dose adjustments due to diminished renal function which may increase drug concentration. In case of overdose, serious symptoms such as respiratory depression may occur, so appropriate medical treatment should be sought immediately at a hospital. When using injections, there is a risk of arrhythmias or blood pressure drops due to rapid intravenous administration, so slow infusion is necessary. This medication should be stored out of the reach of children, and transferring it to other containers may lead to degradation of quality or accidents, so caution is needed.

Side effects

Leukopenia, neutropenia, agranulocytosis, thrombocytopenia, pancytopenia, aplastic anemia, generalized weakness, asthenia, subcutaneous hemorrhage, mucosal hemorrhage, fever, autoimmune hemolytic anemia, jaundice, hepatitis, elevation of AST, elevation of ALT, liver dysfunction, perivenous liver fibrosis, interstitial seizures, acute renal failure, interstitial nephritis, urinary retention, elevation of BUN, elevation of serum creatinine, shock, anaphylactoid reaction, hypersensitivity vasculitis, rash, gynecomastia, galactorrhea, increase in leukorrhea, erectile dysfunction, abdominal distension, constipation, diarrhea, headache, dizziness, seizures, limb numbness, rigidity, drowsiness, hypochondriac symptoms, disturbance of consciousness, confusion, bradycardia, tachycardia, palpitations, heart block, mucocutaneous syndrome, toxic epidermal necrolysis, epidermal necrosis, erythema multiforme, exfoliative dermatitis, generalized exfoliative erythema with edema, fatigue, generalized heat sensation, dysuria, myalgia, arthralgia, pancreatitis, hair loss, polymyositis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius at room temperature. Proper storage like this helps to maintain the efficacy of the medication for a longer duration.

Appearance and packaging

Appearance

Light green film-coated tablet

Package unit

30, 600 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.